European Pharmaceutical Review

UK-US post-Brexit trade deal risks increased drug prices
A trade deal between the UK and USA could risk increasing drug prices in the UK, which could diminish the affordability and accessibility of the NHS...
Innovation and leadership drive success
As part of EPR’s Women inspiring Pharma series, Gowri Sukumar, Associate Director, CMC and Regulatory Affairs at ESSA Pharmaceuticals, talks to Science Editor Dr Zara Kassam about having a positive mindset, diversity and the key to success…
Scientific Poster & Whitepaper Gallery 2018
This supplement brings together leading companies with compelling science stories to share in a simple-to-understand format.
Immunotherapy drug could boost hormone treatment for prostate cancer
Researchers believe the combination with established treatment could improve outcomes in prostate cancer...

#soliloquy-container-60099{opacity:1}#soliloquy-container-60099 li>.soliloquy-caption{display:none}#soliloquy-container-60099 li:first-child>.soliloquy-caption{display:block} UK-US post-Brexit trade deal risks increased drug prices